Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Delforge

Showing results (81-90 of 188) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|July 27, 2023
An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myelomaPaula Rodríguez Otero, Kevin Towle, Shannon Cope, et al.
British Journal of Haematology|November 19, 2014
Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasoneGareth Morgan, Antonio Palumbo, Sujith Dhanasiri, et al.
Nature Communications|February 7, 2018
Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genesJasper Edgar Neggers, Bert Kwanten, Tim Dierckx, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|June 16, 2026
Proteomic profiling of whole tissue sections in cardiac ATTR amyloidosis reveals increased extracellular matrix remodelingAnnelore Vandendriessche, Teresa M Maia, Frank Timmermans, et al.
Hemasphere|September 4, 2023
Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice: A Modified Delphi StudyKarthik Ramasamy, Hervé Avet-Loiseau, Cecilie Hveding Blimark, et al.
Histopathology|May 14, 2026
Confirmation of monotypic immunofluorescence staining by mass spectrometry in a case of proliferative glomerulonephritisLyssa Van De Ginste, Annelore Vandendriessche, An S De Vriese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
In utero exposure to chemotherapy: effect on cardiac and neurologic outcomeKristel Van Calsteren, Patrick Berteloot, Myriam Hanssens, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 9, 2024
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in the native or posttransplant kidneyMargo Verbinnen, Ben Sprangers, Alferso C Abrahams, et al.
Leukemia Research|August 5, 2022
Patient experience before and after treatment with idecabtagene vicleucel (ide-cel, bb2121): qualitative analysis of patient interviews in the KarMMa trialNina Shah, Michel Delforge, Jesus San-Miguel, et al.
The Lancet. Haematology|December 22, 2015
Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle studyPeter Vandenberghe, Iwona Wlodarska, Thomas Tousseyn, et al.
Pageof 19

Showing results (81-90 of 188) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|July 27, 2023
An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myelomaPaula Rodríguez Otero, Kevin Towle, Shannon Cope, et al.
British Journal of Haematology|November 19, 2014
Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasoneGareth Morgan, Antonio Palumbo, Sujith Dhanasiri, et al.
Nature Communications|February 7, 2018
Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genesJasper Edgar Neggers, Bert Kwanten, Tim Dierckx, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|June 16, 2026
Proteomic profiling of whole tissue sections in cardiac ATTR amyloidosis reveals increased extracellular matrix remodelingAnnelore Vandendriessche, Teresa M Maia, Frank Timmermans, et al.
Hemasphere|September 4, 2023
Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice: A Modified Delphi StudyKarthik Ramasamy, Hervé Avet-Loiseau, Cecilie Hveding Blimark, et al.
Histopathology|May 14, 2026
Confirmation of monotypic immunofluorescence staining by mass spectrometry in a case of proliferative glomerulonephritisLyssa Van De Ginste, Annelore Vandendriessche, An S De Vriese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
In utero exposure to chemotherapy: effect on cardiac and neurologic outcomeKristel Van Calsteren, Patrick Berteloot, Myriam Hanssens, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 9, 2024
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in the native or posttransplant kidneyMargo Verbinnen, Ben Sprangers, Alferso C Abrahams, et al.
Leukemia Research|August 5, 2022
Patient experience before and after treatment with idecabtagene vicleucel (ide-cel, bb2121): qualitative analysis of patient interviews in the KarMMa trialNina Shah, Michel Delforge, Jesus San-Miguel, et al.
The Lancet. Haematology|December 22, 2015
Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle studyPeter Vandenberghe, Iwona Wlodarska, Thomas Tousseyn, et al.
Pageof 19